Two Sigma Investments’s Medicines Co MDCO Stock Holding History

Two Sigma Investments’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-57,282	Closed	-$4.87M	–	4144
2019 Q4	$4.87M	Buy	+57,282	New	+$3.82M	0.01%	970
2019 Q3	–	Sell	-241,882	Closed	-$8.82M	–	3961
2019 Q2	$8.82M	Buy	241,882 +231,700	+2,276%	+$7.56M	0.03%	644
2019 Q1	$285K	Buy	+10,182	New	+$240K	﹤0.01%	2634
2018 Q3	–	Sell	-9,282	Closed	-$341K	–	3797
2018 Q2	$341K	Buy	+9,282	New	+$302K	﹤0.01%	2872
2016 Q1	–	Sell	-17,204	Closed	-$642K	–	3261
2015 Q4	$642K	Buy	+17,204	New	+$650K	﹤0.01%	1813
2015 Q2	–	Sell	-9,246	Closed	-$259K	–	3228
2015 Q1	$259K	Sell	9,246 -25,080	-73%	-$704K	﹤0.01%	2354
2014 Q4	$950K	Buy	+34,326	New	+$850K	0.01%	1401
2014 Q3	–	Sell	-24,352	Closed	-$708K	–	2201
2014 Q2	$708K	Sell	24,352 -74,893	-75%	-$2M	﹤0.01%	1460
2014 Q1	$2.82M	Buy	+99,245	New	+$3.28M	0.02%	818

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Two Sigma Investments's MDCO Position: Q1 2020 in Review

Two Sigma Investments sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 57,282 shares — an estimated $4.87M sold.

Two Sigma Investments first reported a position in MDCO in Q1 2014 and held it in 9 quarters. The position peaked at $8.82M in Q2 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Two Sigma Investments reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Two Sigma Investments sold 57,282 Medicines Co shares in Q1 2020, an estimated $4.87M.
Two Sigma Investments first reported a position in Medicines Co in Q1 2014 and held it in 9 quarters.
Two Sigma Investments's Medicines Co position peaked at $8.82M in Q2 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Two Sigma Investments's 13F filing for Q1 2020, filed 15 May 2020.